It is very nice to visit Lambda facility and thanks to warm welcome provided by all the teams. I can easily say one of the best CRO I ever visited. People here are wonderful and doing great job

Reputed Client of Israel

Awesome hospitality & fantastic office. All the best!

Reputed Client of Japan

Excellent hospitality and cooperation received throughout the audit. People are knowledgeable and extremely transparent. Looking for long time relation

Reputed Client of Asia

Facility is too good to conduct the BABE studies and adherence to protocol and quality assurance in conducting studies are meeting sponsor expectations and requirements.

Reputed Client of India

Facility is good, people r trained well and know the subject on which they r working. All the best.

Reputed Client of USA

Highly innovative and advanced research centre that possess bright future for the development of the country.

Reputed International Government Body

It is one of the best facility in India for BA/BE

Reputed Regulatory Authority

Lambda is a very professional CRO. All the staff here are experienced and very knowledgeable. I'm grateful for their accommodations and hospitality. The future, if we want to carry out BE study, we will ask Lambda help again.

Reputed Client of Europe

It was a really pleasant meeting with the PV department, and I am looking forward to the next visit.

Reputed Client of Europe

Amazing and best CRO I ever seen

Reputed Client of China



Home / Blog

Ensuring Accurate Outcomes: Meeting Regulatory Requirements & Generating Clinical Evidence for Future Research

11 Jul 2023

Clinical trials play a crucial role in assessing the safety and effectiveness of new treatments through prospective studies involving human participants. These trials span across small and large-scale populations, including both healthy volunteers and patients. The successful execution of a clinical trial involves meticulous planning, precise data collection, performing bioanalytical, clinical & statistical analysis, and the preparation of comprehensive reports, dossiers, and submissions to regulatory authorities for marketing authorization.

The accuracy of the study outcomes relies heavily on correct data collection and analysis. To present the clinical study outcomes with precision, a Clinical Study Report (CSR) is prepared. This comprehensive document provides a structured and detailed summary of the trial's design, methodology, results, and analysis. The CSR serves as a crucial component of the clinical research process.

However, a question arises: What if the presentation of the trial's outcomes is flawed? What if the final report contains biased results? To address these concerns, CSRs adhere to regulatory guidelines, such as those set by the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH). These guidelines establish standard formats and content requirements, ensuring consistency, clarity, and comprehensiveness. This allows for accurate evaluation and interpretation of the study outcomes.

At Lambda Therapeutic Research, we prioritize addressing these concerns and ensuring compliance with regulatory submissions. Lambda has successfully submitted numerous clinical study reports and related documents to various regulatory bodies.

We aim to provide transparent and explicit outcome results of conducted trials to:

  • Increase the frequency of researcher appraising the trial.
  • Impactful evidence synthesis
  • Improve decision-making.
  • Improved health-related quality of life of patients

To ensure the efficacious provision of data, we focus on the following criteria:

  • Documentation of Study Results: We meticulously document the study design, methodology, results, and analysis, providing a comprehensive overview of the trial.
  • Scientific Integrity: We outline the methods used, data collected, and statistical analyses conducted, allowing for independent evaluation and verification of the study findings.
  • Regulatory Compliance: Our well-prepared CSRs strictly adhere to regulatory guidelines, facilitating the approval process for new drugs or therapies.
  • Data Transparency: We provide detailed information on study participants while maintaining confidentiality, treatment interventions, adverse events, and statistical analysis, ensuring transparency throughout the trial.
  • Quality Control: Our CSRs undergo rigorous quality control processes, including data validation, statistical analysis, and expert review. This ensures the accuracy, reliability, and consistency of the study results, further enhancing the credibility of the research.
  • Expert Medical Review: Clinical trials' safety and efficacy outcomes are being sustained with critical evaluation by the qualified medical team to ensure data accuracy.
  • Evidence-Based Decision-Making, Future Research, and Development: By offering comprehensive data on the safety and efficacy of drugs or treatments, we empower healthcare professionals to make evidence-based decisions and drive future research and development.

Lambda has successfully submitted 5000+ clinical trial reports, encompassing phases I to IV, to regulatory authorities across multiple countries.

Country Regulatory Body
Africa South African Health Products Regulatory Authority (SAHPRA)
Australia Therapeutic Goods Administration (TGA)
Brazil Agencia Nacional de Vigilancia Sanitaria (ANVISA)
Canada Health Canada
China National Medical Products Administration (NMPA)
European countries The European Medicines Agency (EMA)
India Drug Controller General of India (DCGI)
Israel Israeli Ministry of Health (MoH)
Malaysia & Thailand The Association of Southeast Asian Nations (ASEAN)
United States United States Food and Drug Administration (USFDA)

Contact us to leverage our proven track record of excellence and expedite your research.

Looking for a Globally Proven Research Partner?

Contact Us